<p>制药制造商将受益于深厚的专业知识和广泛的分销网络，以及宜瑞安的功能性辅料。</p>
<p>, /PRNewswire/ -- Univar Solutions LLC（&#34;Univar Solutions&#34;或&#34;公司&#34;）是一家领先的全球特种成分和化学品解决方案提供商，今天宣布其 Ingredients + Specialties 部门被任命为宜瑞安制药解决方案的分销商，宜瑞安制药解决方案是宜瑞安公司（NYSE: INGR）的一部分。该协议包括宜瑞安全球制药产品组合的分销，并将公司定位为美国和加拿大制药淀粉的独家分销商。这一战略合作伙伴关系使 Ingredients + Specialties 能够进一步多样化和增强其制药和营养保健成分组合，提供广泛的功能性辅料，包括直接压片和湿法造粒粘合剂、片剂和胶囊的填充剂、超解离剂、润滑剂、用于包封的乳液以及素食软胶囊配方的明胶替代品。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919293/Univar_Solutions_Ingredients_and_Specialties.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919293/Univar_Solutions_Ingredients_and_Specialties.jpg"/></p>
<p>我们很高兴能够扩展我们的产品范围，同时加深与宜瑞安的合作关系。</p>
<p>&#34;我们很高兴能够扩展我们的产品范围，同时加深与宜瑞安的合作关系，&#34;Univar Solutions 健康与营养全球高级副总裁 Aaron Lee 表示。&#34;通过这项协议，我们将扩大在美国和加拿大对制药淀粉和其他功能性辅料的获取，帮助我们的制药和营养保健客户解决配方挑战并发展他们的业务。这一合作关系真正体现了我们将客户与高质量成分和定制市场解决方案连接起来的承诺，我们对这一合作能够提升制片、软胶囊和包封应用充满信心。&#34;</p>
<p>宜瑞安制药解决方案是宜瑞安公司的一部分，宜瑞安是一家全球成分解决方案提供商，生产功能性成分，包括旨在提高配方性能的制药级淀粉，帮助克服在各种制药和营养保健应用中遇到的技术挑战。通过该协议，Univar Solutions 的 Ingredients + Specialties 将分销宜瑞安的制药产品组合，并在美国和加拿大独家分销基于淀粉的制药辅料，包括 UNI-PURE® F、UNI-PURE® FL、UNI-PURE® GA 和 UNI-PURE® WG-220。</p>
<p>&#34;我们很高兴能够在制药淀粉、甘露醇和特种辅料产品领域与 Univar Solutions 的 Ingredients + Specialties 扩展我们的合作关系，&#34;宜瑞安美国和加拿大制药高级销售经理 Joe Rogus 表示。&#34;他们是一家世界级组织，在向制药市场提供高价值特种产品和服务方面拥有出色的业绩记录。我们相信，这一合作将推动成分创新，并为我们的客户提供卓越的价值。&#34;</p>
<p>Univar Solutions 的 Ingredients + Specialties 产品组合是创新和分销领域最值得信赖的名称之一，提供品牌和制造商开发新产品和改进产品所需的基本特种成分，以满足客户的需求。该产品组合得到了他们对创新、可持续性和质量的承诺的支持，以及技术支持和配方专业知识，以帮助确保客户和供应商能够自信和创造性地应对行业快速变化的未来。</p>
<p>探索 Univar Solutions 的 Ingredients + Specialties 与宜瑞安制药解决方案之间的关系如何提升配方性能并解决技术挑战。</p>
<p><strong>关于 Univar Solutions</strong> Univar Solutions 是一家领先的全球特种化学品和成分分销商，代表来自全球领先生产商的优质产品组合。凭借行业最大的私人运输车队和技术销售团队、无与伦比的物流专业知识、深厚的市场和监管知识、配方和配方开发以及领先的数字工具，公司在为广泛的市场、行业和应用提供量身定制的解决方案和增值服务方面处于良好位置。在履行其帮助保持社区健康、供给、清洁和安全的使命的同时，Univar Solutions 致力于帮助客户和供应商创新，专注于共同成长。了解更多信息，请访问 univarsolutions.com。</p>
<p><strong>关于 Univar Solutions 的 Ingredients + Specialties</strong> Univar Solutions 的 Ingredients + Specialties 为寻求推动现代生活的特种客户和供应商提供最佳产品、人才和成果。通过将科学、创新和深厚的专业知识与领先的特种产品组合相结合，我们帮助找到安全改善全球生活和社区所需的解决方案。了解更多信息，请访问 univarsolutions.com。</p>
<p><strong>关于宜瑞安制药解决方案</strong></p>
<p>宜瑞安公司（NYSE: INGR）是一家全球创新成分解决方案提供商。对于制药和营养保健，我们与寻求功能性材料以提高配方性能并克服技术挑战的客户合作。我们的解决方案包括粘合剂、填充剂、超解离剂、润滑剂、素食软胶囊的增塑剂、用于包封的乳液和注射用原料药。我们正在不断转型，结合 cGMP 设施、监管支持、全球存在和技术支持，成为客户值得信赖的配方问题解决合作伙伴。要了解更多信息，请访问 ingredionpharma.com/。</p>
<p><strong>前瞻性声明和信息</strong> 本通信包含根据适用法律关于公司业务的财务和运营事项的 “前瞻性声明”。前瞻性声明通常可以通过诸如 “相信”、“预计”、“可能”、“将”、“应该”、“能够”、“寻求”、“打算”、“计划”、“估计”、“预期” 或其他类似术语来识别。本通信中所作的所有前瞻性声明均受到此警示性语言的限制。</p>
<p>前瞻性声明受到已知和未知的风险和不确定性的影响，其中许多可能超出公司的控制范围，这可能导致预期未能实现，或以其他方式对公司的业务、财务状况、运营结果或现金流产生重大不利影响。尽管前瞻性声明是基于管理层认为合理的假设，但我们提醒您，本通信中所呈现的前瞻性信息并不保证未来事件或结果，实际事件或结果可能与本通信中所包含的前瞻性信息所作或暗示的内容有重大差异。有关可能影响公司的因素的更多信息，请参见公司的最新年度报告和其他财务报告，包括 “风险因素” 标题下所列的信息。任何前瞻性声明仅代表公司在本通信日期的观点，不应被视为公司在任何后续日期的观点，公司不承担任何更新任何前瞻性声明的义务，除非法律要求。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919294/Ingredion_x_Univar_Solutions.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919294/Ingredion_x_Univar_Solutions.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2352471/Univar_Solutions_LLC_Logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2352471/Univar_Solutions_LLC_Logo.jpg"/></p>
<p>来源：Univar Solutions LLC</p>

宜瑞安

<p>Univar Solutions 已被任命为 Ingredion Pharma Solutions 在美国和加拿大的独家分销商。此次合作使 Univar 能够分销 Ingredion 的药用淀粉和功能性辅料，增强其在制药和营养保健领域的产品组合。该合作旨在解决配方挑战，并改善客户的产品供应。Univar Solutions 强调其在提供特种成分方面对创新和质量的承诺</p>

<p><em>Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipients</em></p>
<div class="lb-trans"><p>制药制造商将受益于深厚的专业知识和广泛的分销网络，以及宜瑞安的功能性辅料。</p>
</div><p>, /PRNewswire/ -- Univar Solutions LLC (&#34;Univar Solutions&#34; or &#34;the Company&#34;), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients + Specialties from Univar Solutions division has been appointed as a distributor for Ingredion Pharma Solutions, part of Ingredion Incorporated (NYSE: INGR). The agreement includes distribution of Ingredion's global pharmaceuticals portfolio and positions the Company as the exclusive distributor of pharmaceutical starches in the United States and Canada. This strategic partnership enables Ingredients + Specialties to further diversify and strengthen its pharmaceutical and nutraceutical ingredients portfolios with a broad range of functional excipients, including direct compression and wet granulation binders, fillers for tablets and capsules, superdisintegrants, lubricants, emulsion for encapsulation, and gelatin replacements for vegetarian softgel formulations.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Univar Solutions LLC（&#34;Univar Solutions&#34;或&#34;公司&#34;）是一家领先的全球特种成分和化学品解决方案提供商，今天宣布其 Ingredients + Specialties 部门被任命为宜瑞安制药解决方案的分销商，宜瑞安制药解决方案是宜瑞安公司（NYSE: INGR）的一部分。该协议包括宜瑞安全球制药产品组合的分销，并将公司定位为美国和加拿大制药淀粉的独家分销商。这一战略合作伙伴关系使 Ingredients + Specialties 能够进一步多样化和增强其制药和营养保健成分组合，提供广泛的功能性辅料，包括直接压片和湿法造粒粘合剂、片剂和胶囊的填充剂、超解离剂、润滑剂、用于包封的乳液以及素食软胶囊配方的明胶替代品。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919293/Univar_Solutions_Ingredients_and_Specialties.jpg" alt="" original-src="https://mma.prnewswire.com/media/2919293/Univar_Solutions_Ingredients_and_Specialties.jpg"/></p>
<p>We are thrilled to enhance our product range while deepening our partnership with Ingredion.</p>
<div class="lb-trans"><p>我们很高兴能够扩展我们的产品范围，同时加深与宜瑞安的合作关系。</p>
</div><p>&#34;We are thrilled to enhance our product range while deepening our partnership with Ingredion,&#34; said Aaron Lee, global senior vice president of Health &amp; Nutrition for Univar Solutions. &#34;Through this agreement, we will expand access to pharmaceutical starches and other functional excipients in the United States and Canada, helping our pharmaceutical and nutraceutical customers address formulation challenges and grow their businesses. This partnership truly underscores our commitment connecting customers to high-quality ingredients and customized market solutions, and we are optimistic that the collaboration will help enhance tableting, softgel, and encapsulation applications.&#34;</p>
<div class="lb-trans"><p>&#34;我们很高兴能够扩展我们的产品范围，同时加深与宜瑞安的合作关系，&#34;Univar Solutions 健康与营养全球高级副总裁 Aaron Lee 表示。&#34;通过这项协议，我们将扩大在美国和加拿大对制药淀粉和其他功能性辅料的获取，帮助我们的制药和营养保健客户解决配方挑战并发展他们的业务。这一合作关系真正体现了我们将客户与高质量成分和定制市场解决方案连接起来的承诺，我们对这一合作能够提升制片、软胶囊和包封应用充满信心。&#34;</p>
</div><p>Ingredion Pharma Solutions, part of Ingredion, a global ingredient solutions provider, produces functional ingredients, including pharmaceutical-grade starches designed to enhance formulation performance and help overcome the technical challenges experienced in various pharmaceutical and nutraceutical applications. Through the agreement, Ingredients + Specialties from Univar Solutions will distribute Ingredion's pharma portfolio and is the exclusive distributor in the United States and Canada for the Pharma starch-based excipients including UNI-PURE® F, UNI-PURE® FL, UNI-PURE® GA, and UNI-PURE® WG-220.</p>
<div class="lb-trans"><p>宜瑞安制药解决方案是宜瑞安公司的一部分，宜瑞安是一家全球成分解决方案提供商，生产功能性成分，包括旨在提高配方性能的制药级淀粉，帮助克服在各种制药和营养保健应用中遇到的技术挑战。通过该协议，Univar Solutions 的 Ingredients + Specialties 将分销宜瑞安的制药产品组合，并在美国和加拿大独家分销基于淀粉的制药辅料，包括 UNI-PURE® F、UNI-PURE® FL、UNI-PURE® GA 和 UNI-PURE® WG-220。</p>
</div><p>&#34;We are excited to expand our partnership with Ingredients + Specialties from Univar Solutions in the pharmaceutical starches, mannitol, and specialty excipients product space,&#34; said Joe Rogus, pharma senior sales manager – United States and Canada for Ingredion. &#34;They are a world-class organization with an excellent track record in delivering high-value specialty products and services to pharmaceutical markets. We're confident that this collaboration will drive ingredient innovation and deliver exceptional value to our customers.&#34;</p>
<div class="lb-trans"><p>&#34;我们很高兴能够在制药淀粉、甘露醇和特种辅料产品领域与 Univar Solutions 的 Ingredients + Specialties 扩展我们的合作关系，&#34;宜瑞安美国和加拿大制药高级销售经理 Joe Rogus 表示。&#34;他们是一家世界级组织，在向制药市场提供高价值特种产品和服务方面拥有出色的业绩记录。我们相信，这一合作将推动成分创新，并为我们的客户提供卓越的价值。&#34;</p>
</div><p>The Ingredients + Specialties portfolio from Univar Solutions—one of the most trusted names in innovation and distribution—offers the essential specialty ingredients needed for brands and manufacturers to develop new and improved products that deliver results for their customers. The portfolio is backed by their commitment to innovation, sustainability, and quality, as well as technical support and formulation expertise to help ensure customers and suppliers are equipped to navigate the industry's rapidly changing future with confidence and creativity.</p>
<div class="lb-trans"><p>Univar Solutions 的 Ingredients + Specialties 产品组合是创新和分销领域最值得信赖的名称之一，提供品牌和制造商开发新产品和改进产品所需的基本特种成分，以满足客户的需求。该产品组合得到了他们对创新、可持续性和质量的承诺的支持，以及技术支持和配方专业知识，以帮助确保客户和供应商能够自信和创造性地应对行业快速变化的未来。</p>
</div><p>Explore how the relationship between Ingredients + Specialties from Univar Solutions and Ingredion Pharma Solutions enhances formulation performance and addresses technical challenges.</p>
<div class="lb-trans"><p>探索 Univar Solutions 的 Ingredients + Specialties 与宜瑞安制药解决方案之间的关系如何提升配方性能并解决技术挑战。</p>
</div><p><strong>About Univar Solutions</strong> Univar Solutions is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world's leading producers. With the industry's largest private transportation fleet and technical sales force, unparalleled logistics know-how, deep market and regulatory knowledge, formulation and recipe development, and leading digital tools, the Company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. While fulfilling its purpose to help keep communities healthy, fed, clean, and safe, Univar Solutions is committed to helping customers and suppliers innovate and focus on Growing Together. Learn more at univarsolutions.com.</p>
<div class="lb-trans"><p><strong>关于 Univar Solutions</strong> Univar Solutions 是一家领先的全球特种化学品和成分分销商，代表来自全球领先生产商的优质产品组合。凭借行业最大的私人运输车队和技术销售团队、无与伦比的物流专业知识、深厚的市场和监管知识、配方和配方开发以及领先的数字工具，公司在为广泛的市场、行业和应用提供量身定制的解决方案和增值服务方面处于良好位置。在履行其帮助保持社区健康、供给、清洁和安全的使命的同时，Univar Solutions 致力于帮助客户和供应商创新，专注于共同成长。了解更多信息，请访问 univarsolutions.com。</p>
</div><p><strong>About Ingredients + Specialties from Univar Solutions</strong> Ingredients + Specialties from Univar Solutions brings the best products, people, and results to specialty customers and suppliers seeking to power modern life. By combining science, innovation, and deep expertise with a leading specialty portfolio, we help find the solutions needed to safely improve lives and communities across the globe. Learn more at univarsolutions.com.</p>
<div class="lb-trans"><p><strong>关于 Univar Solutions 的 Ingredients + Specialties</strong> Univar Solutions 的 Ingredients + Specialties 为寻求推动现代生活的特种客户和供应商提供最佳产品、人才和成果。通过将科学、创新和深厚的专业知识与领先的特种产品组合相结合，我们帮助找到安全改善全球生活和社区所需的解决方案。了解更多信息，请访问 univarsolutions.com。</p>
</div><p><strong>About Ingredion Pharma Solutions</strong></p>
<div class="lb-trans"><p><strong>关于宜瑞安制药解决方案</strong></p>
</div><p>Ingredion Incorporated (NYSE: INGR) is a global innovative ingredient solutions provider. For Pharma &amp; Nutraceuticals, we partner with customers seeking functional materials to enhance the performance of formulations and overcome their technical challenges. Our solutions include binders, fillers, superdisintegrants, lubricants, plasticizer, gelatine replacers for veggie softgel, emulsions for encapsulation, and parenteral APIs. We are in the continuous transformation to combine cGMP facilities, regulatory assistance, global presence, and technical support to be a trusted formulation problem-solving partner to our customers. To learn more, access ingredionpharma.com/</p>
<div class="lb-trans"><p>宜瑞安公司（NYSE: INGR）是一家全球创新成分解决方案提供商。对于制药和营养保健，我们与寻求功能性材料以提高配方性能并克服技术挑战的客户合作。我们的解决方案包括粘合剂、填充剂、超解离剂、润滑剂、素食软胶囊的增塑剂、用于包封的乳液和注射用原料药。我们正在不断转型，结合 cGMP 设施、监管支持、全球存在和技术支持，成为客户值得信赖的配方问题解决合作伙伴。要了解更多信息，请访问 ingredionpharma.com/。</p>
</div><p><strong>Forward-Looking Statements and Information</strong> This communication contains &#34;forward-looking statements&#34; under applicable law regarding financial and operating items relating to the Company's business. Forward-looking statements generally can be identified by words such as &#34;believes,&#34; &#34;expects,&#34; &#34;may,&#34; &#34;will,&#34; &#34;should,&#34; &#34;could,&#34; &#34;seeks,&#34; &#34;intends,&#34; &#34;plans,&#34; &#34;estimates,&#34; &#34;anticipates&#34; or other comparable terms. All forward-looking statements made in this communication are qualified by this cautionary language.</p>
<div class="lb-trans"><p><strong>前瞻性声明和信息</strong> 本通信包含根据适用法律关于公司业务的财务和运营事项的 “前瞻性声明”。前瞻性声明通常可以通过诸如 “相信”、“预计”、“可能”、“将”、“应该”、“能够”、“寻求”、“打算”、“计划”、“估计”、“预期” 或其他类似术语来识别。本通信中所作的所有前瞻性声明均受到此警示性语言的限制。</p>
</div><p>Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control, that could result in expectations not being realized or could otherwise materially and adversely affect the Company's business, financial condition, results of operations or cash flows. Although the forward-looking statements are based on what management believes to be reasonable assumptions, we caution you that the forward-looking information presented in this communication is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this communication. For additional information regarding factors that could affect the Company, please see the Company's most recent annual report and other financial reports, including the information set forth under the caption &#34;Risk Factors.&#34; Any forward-looking statements represent the Company's views only as of the date of this communication and should not be relied upon as representing the Company's views as of any subsequent date, and the Company undertakes no obligation, other than as may be required by law, to update any forward-looking statement.</p>
<div class="lb-trans"><p>前瞻性声明受到已知和未知的风险和不确定性的影响，其中许多可能超出公司的控制范围，这可能导致预期未能实现，或以其他方式对公司的业务、财务状况、运营结果或现金流产生重大不利影响。尽管前瞻性声明是基于管理层认为合理的假设，但我们提醒您，本通信中所呈现的前瞻性信息并不保证未来事件或结果，实际事件或结果可能与本通信中所包含的前瞻性信息所作或暗示的内容有重大差异。有关可能影响公司的因素的更多信息，请参见公司的最新年度报告和其他财务报告，包括 “风险因素” 标题下所列的信息。任何前瞻性声明仅代表公司在本通信日期的观点，不应被视为公司在任何后续日期的观点，公司不承担任何更新任何前瞻性声明的义务，除非法律要求。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2919294/Ingredion_x_Univar_Solutions.jpg" alt="" original-src="https://mma.prnewswire.com/media/2919294/Ingredion_x_Univar_Solutions.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2352471/Univar_Solutions_LLC_Logo.jpg" alt="" original-src="https://mma.prnewswire.com/media/2352471/Univar_Solutions_LLC_Logo.jpg"/></p>
<p>SOURCE Univar Solutions LLC</p>
<div class="lb-trans"><p>来源：Univar Solutions LLC</p>
</div>

Univar Solutions 被选定为宜瑞安制药解决方案在美国和加拿大的分销商 | INGR 股票新闻